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e.g. zolpidem. In order to define what potentially inappropritate use of BZD
is, we need to look into the simultaneous use of multiple BZDs which is not
uncommon and deserves to be further studied. Efforts also need to characterize
potential heavy users, in order to ensure that BZDs are used most effectively and
their untowards effects are minimized.
P-06.32 Corpus callosum damage in heavy marijuana use: preliminary
evidence from diffusion tensor tractography and tract-based
spatial statistics
M. Abou-Saleh1, D. Arnone1, T.R. Barrick2, S. Chengappa1, C.A. Clark3,
C.E. Mackay4. 1University of London, Mental Health, United Kingdom;
2University of London, Cardiac and Cascular Sciences, United Kingdom;
3University of London, Radiology and Physics Unit, United Kingdom;
4University of Oxford, Dept. of Psychiatry, United Kingdom
Objective: Heavy marijuana use has well established long term consequences
for cognition and mental health, but the effect on brain structure is less well
understood. We used an MRI technique that is sensitive to the structural integrity
of brain tissue combined with a white matter mapping tractography technique to
investigate structural changes in the corpus callosum (CC).
Methods: Diffusion tensor imaging (DTI) was obtained in eleven heavy
marijuana users who started using marijuana in early adolescence and eleven age
matched controls. Mean diffusivity (MD) and fractional anisotropy (FA) (which
measure structural integrity and tract coherence, respectively) were analysed
within the corpus callosum which was spatially defined using tractography and
tract-based spatial statistics (TBSS).
Results:MD was significantly increased in marijuana users relative to controls
in the region of the CC where white matter passes between the prefrontal lobes.
This observation suggests impaired structural integrity affecting the fibre tracts of
the CC and is in keeping with previous reports of altered and diversified activation
patterns in marijuana users. There was a trend towards a positive correlation
between MD and length of use suggesting the possibility of a cumulative effect
of marijuana over time and that a younger age at onset of use may predispose
individuals to structural white matter damage.
Conclusion: Structural abnormalities revealed in the CC may underlie cogni-
tive and behavioural consequences of long term heavy marijuana use.
P-06.33 Comparative study of haloperidol and olanzapine in cannabis
induced psychotic disorder
S. Momtazi1, F. Taremian1. 1Zanjan Medical University, Psychiatry, Islamic
Republic of Iran
Objective: There are different ideas about prevalence and treatment of cannabis
induced psychotic disorder. It is shown that high doses can lead to psychotic
symptoms. Abuse of more potent and pure form of cannabis as“Hashish” is
relatively prevalent In Iran. Some studies have shown successful treatment of this
disorder with different antipsychotic drugs. In this study we aimed at comparing
olanzapine with halopridol in cannabis induced psychotic disorder.
Methods: 21 patients including 19 male and 2 female with diagnosis of
cannabis induced psychotic disorder according to DSM-IV-TR criteria were
randomly divided into two groups to receive either haloperidol (11 patients)
or olanzapine (10 patients) for a six a week trial. Mean age was 22.7 years.
Assessments were conducted at baseline and after two, four and six weeks
treatment using Brief Psychiatric Rating Scale.
Results: We used haloperidol in a dose between 5−20 mg daily and olanzapine
in a dose between 2.5−10 mg daily. There was not a significant difference
between two groups on Brief Psychiatric Rating Scale at the end of treatment.
Mean haloperidol group 39.07 versus olanzapine 40.43 (p = 0.23). Comparing
extrapyramidal adverse effects haloperidol group with use of Simpson Angus
Scale showed significantly more side effects and they needed more to anticholin-
ergic drugs such as biperidine for continuing treatment. Sedation was more in
olanzapine group.
Conclusion: Olanzapine can be as effective as haloperidal for cannabis
induced psychotic disorder. Olanzapine is associated with lower extrapyramidal
side effects but more sedative effects.
P-06.34 Visuospatial memory deficits in long term heavy cannabis
users: Relation to psychotic symptoms and regional brain
volumes
N. Solowij1, C. Respondek1, R. Battisti1, S. Whittle2, D. Lubman3, M. Yücel2.
1University of Wollongong, School of Psychology, Wollongong, NSW, Australia;
2University of Melbourne, Melbourne Neuropsychiatry Centre, Melbourne VIC,
Australia; 3University of Melbourne, ORYGEN Research Psychiatry, Parkville,
VIC, Australia
Objective: Verbal episodic memory has been extensively investigated in long
term heavy cannabis users and most studies have found impaired learning
and memory processes in this domain. Less attention has been devoted to
studying visuospatial memory processes in this population. Recently we reported
reduced hippocampal and amygdala volumes in long term heavy cannabis users
which were related to subthreshold psychotic symptoms. This study assessed
visuospatial memory in cannabis users and examined relations with symptoms
and neural substrates.
Methods: 100 healthy participants (51 cannabis users, 49 non-user controls)
completed four tests of visuospatial memory function from the Cambridge
Neuropsychological Test Automated Battery (CANTAB): Spatial Recognition
Memory (SRM), Spatial Span (SSP), Spatial Working Memory (SWM) and
visuospatial Paired Associate Learning (PAL). Groups were matched on most
demographic characteristics and other substance use was minimal in the sample.
Subthreshold psychotic symptoms were assessed using the Scales for the As-
sessment of Postive and Negative Symptoms (SAPS and SANS) and the Brief
Symptom Inventory. For 15 users and 16 controls, detailed anatomical brain
scans were also obtained.
Results: Cannabis users and controls did not differ in age, but users had a
marginally lower WAIS-R full scale IQ. Cannabis users showed significantly
lower percent correct responses in SRM (p< 0.02), a smaller spatial span
(p< 0.04), greater errors (p< 0.0001) and poorer strategy in SWM (p< 0.0005),
and more errors in PAL (p< 0.03). None of the measures correlated with IQ, but
differences were nevertheless retained when IQ was controlled. There were trends
toward smaller spatial span (p< 0.07) and greater errors on PAL (p< 0.03) as a
function of increasing duration of cannabis use. None of the measures correlated
with subthreshold psychotic symptoms in the cannabis users but associations
were observed between most of the memory indices and volumetric measures
of the orbitofrontal and anterior cingulate cortices, despite the fact that these
measures did not differ significantly between groups. The regional volumes also
correlated with subthreshold psychotic symptoms in the cannabis users as well
as with cannabis use parameters (eg. duration of exposure and cumulative dose
of exposure).
Conclusion: Long term heavy cannabis use is associated with poorer visuospa-
tial memory and subthreshold psychotic symptoms. These functional indices are
related to volumetric measures of orbitofrontal and anterior cingulate cortices.
The findings suggest that long term and heavy cannabis use has widespread
adverse effects. Further research is required to determine whether these adverse
effects recover with abstinence.
P-06.35 Pronounced paranoia as result of a cocaine disulfiram
interaction
J. Mutschler1, A. Diehl2, F. Kiefer2. 1Heidelberg, Germany; 2CIMH Mannheim,
Addiction Medicine, Germany
Objective: Cocaine addiction is a chronic replapsing disorder. Disulfiram has
recently shown to be promising in the treatment of cocaine addiction. Disulfiram
targets the neurotransmitter system by inhibiting the dopamine b-hydroxylase
(DBH) reducing dopamine and increasing norepinephine concentrations in pe-
ripheral and central tissues in both animals and humans. However, the pharmaco-
dynamics by which this drug achieves reduced relapse rates in cocaine dependent
patients is not fully unterstood. Several authors suggested that inhibition of DBH
might represent an important key to success of disulfiram treatment for cocaine
dependence. This modulation of central monoamie levels would induce drug
aversion by provoking symptoms like anxiety, tachycardia and panic following
cocaine taking.
Methods: Case Report.
Results: We now present the clinical data of a serious cocaine-disulfiram-
reaction after relapse with cocaine in a patient who was treated in our outpatient
unit due to an existing cocaine dependence.
Conclusion: Disulfiram seems to be very promising in the treatment of cocaine
dependence. However, this must be confirmed in larger patient populations.
